---
title: eXmoor Pharma vs Hillgene
slug_a: exmoorpharma
slug_b: hillgene
site: cdmo
review_signal_gate: closed
canonical_path: /compare/exmoorpharma/hillgene
---

# eXmoor Pharma vs Hillgene

Side-by-side profile data from each company listing on this directory.

## eXmoor Pharma

- Profile: [/companies/exmoorpharma](/companies/exmoorpharma)

eXmoor Pharma — Integrated cell and gene therapy CDMO with 20+ years of consultancy expertise, offering end-to-end CMC support from early-phase strategy through GMP manufacturing across viral vectors, autologous/allogeneic cell therapies, and RNA technologies.

Services: 9. Modalities: 3. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (9).

### Services

- Viral Vector Manufacturing
- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- mRNA Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Process Development
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- mRNA
- Cell Therapy
- Gene Therapy

### Development capabilities

- Analytical method development
- Formulation development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Max bioreactor: Mid-scale clinical (≤2,000 L)
- Single-Use / Disposable

## Hillgene

- Profile: [/companies/hillgene](/companies/hillgene)

Hillgene — Hillgene is a leading CDMO provider specializing in cell therapy manufacturing, offering end-to-end solutions for CAR-T, TCR-T, CAR-NK, and UCAR-T cell therapies with GMP facilities in Suzhou and Belgium.

Services: 8. Modalities: 3. Indications: 2. Locations: 3. Certifications: 1. The strongest documented coverage currently appears in services (8).

### Services

- Regulatory Affairs
- Lentiviral Vector Manufacturing
- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- mRNA Manufacturing
- Quality Control Testing
- CMC Regulatory Submission Support

### Modalities

- mRNA
- Cell Therapy
- Gene Therapy

### Development capabilities

- Analytical method development
- Formulation development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Cell-Free
- Single-Use / Disposable